Edoxaban to Prevent Catheter Clots in Cancer
Treatments studied
Part of Cancer, Heart & circulation clinical trials.
This study tests whether the blood thinner edoxaban can safely prevent blood clots caused by a central venous catheter in cancer patients. It may be an option if you have a catheter and are not already on blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You have a central venous catheter (a long IV line placed in a large vein).
- You must not be currently taking blood thinners like warfarin or heparin (except for keeping the catheter open).
- You must not have a high risk of serious bleeding (like a stomach ulcer, recent brain or spinal surgery).
- Your overall health should be fairly good (no severe infections, heart failure, or recent blood clots).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a lower dose of the blood thinner apixaban (Eliquis) can safely prevent another blood clot in people with cancer who have a catheter-related clot in their upper arm or neck. It aims to find a balance between preventing clots and reducing bleeding risk.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
This study tests a simple plan for stopping and restarting your blood thinner (DOAC) before and after getting a port or tunneled catheter. It aims to make the procedure safer for people with cancer who need blood thinners.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
Hear when a new Thrombosis, Venous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.